Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-29

Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability and pharmacokinetics of multiple doses of ASP8062 with a single morphine dose in recreational opioid users; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP8062
  • Morphine (morphine)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2021-09-29